Trimodality therapy for stage II-III carcinoma of the esophagus: A dose-ranging study of concurrent capecitabine, docetaxel, and thoracic radiotherapy

Matthew D. Wood, Bassem I. Zaki, Stuart R. Gordon, John E. Sutton, Mikhail Lisovsky, Jiang Gui, Jeffrey A. Bubis, Konstantin H. Dragnev, James R. Rigas

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Trimodality therapy for stage II-III carcinoma of the esophagus: A dose-ranging study of concurrent capecitabine, docetaxel, and thoracic radiotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences